Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-106,500
Closed -$10.9M 5696
2026
Q1
$10.9M Buy
+106,500
New +$12M ﹤0.01% 3437
2023
Q1
Sell
-797,700
Closed -$87.6M 5562
2022
Q4
$87.6M Sell
797,700
-292,100
-27% -$30.2M ﹤0.01% 2084
2022
Q3
$105M Buy
1,089,800
+764,200
+235% +$81.5M ﹤0.01% 1920
2022
Q2
$35.4M Buy
+325,600
New +$37M ﹤0.01% 2727
2015
Q3
Sell
-100,000
Closed -$4.91M 3203
2015
Q2
$4.91M Buy
+100,000
New +$4.8M 0.01% 854

Other funds holding ABT

BlackRock's ABT Position: Q2 2026 in Review

BlackRock increased its Abbott (ABT) stake by 4.7% in Q2 2026, buying an estimated $628M and bringing the position to 152,563,476 shares worth $13.8B. The position accounts for 0.21% of the portfolio, ranked #74.

BlackRock first reported a position in ABT in Q2 2013 and has held it in 53 quarters since. The position peaked at $19.3B in Q4 2021. 2,972 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • BlackRock held 152,563,476 shares of Abbott worth $13.8B as of Q2 2026.
  • BlackRock bought 6,876,018 Abbott shares in Q2 2026, an estimated $628M.
  • Abbott made up 0.21% of BlackRock's portfolio in Q2 2026, its #74 holding.
  • BlackRock first reported a position in Abbott in Q2 2013 and has held it in 53 quarters since.
  • BlackRock's Abbott position peaked at $19.3B in Q4 2021.
  • 2,972 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.